The authors postulated that SNHG4 might upregulate proto-oncogene expression, in particular MET, via the suppression of miR-148a-3p, to promote the increased growth of endometrial tissue outside the uterine cavity and endometriosis lesions [110]. This evidence concerns the gene SNHG4 and endometriosis.